title: ACCF/AHA clopidogrel clinical alert: approaches to the FDA "boxed warning": a report of the American College of Cardiology Foundation Task Force on clinical expert consensus documents and the American Heart Association endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons.
authors.forename: David R
authors.initials: DR
authors.lastname: Holmes
authors.forename: Gregory J
authors.initials: GJ
authors.lastname: Dehmer
authors.forename: Sanjay
authors.initials: S
authors.lastname: Kaul
authors.forename: Dana
authors.initials: D
authors.lastname: Leifer
authors.forename: Patrick T
authors.initials: PT
authors.lastname: O'Gara
authors.forename: C Michael
authors.initials: CM
authors.lastname: Stein
mesh_terms: D026683:Advisory Committees / Q000592:standards*; D000572:American Heart Association; D001189:Aryl Hydrocarbon Hydroxylases / Q000235:genetics / Q000378:metabolism; D002309:Cardiology / Q000592:standards; D000077144:Clopidogrel; D017023:Coronary Angiography / Q000592:standards; D065731:Cytochrome P-450 CYP2C19; D004348:Drug Labeling / Q000379:methods / Q000592:standards*; D005582:Foundations / Q000592:standards; D006801:Humans; D012955:Societies, Medical / Q000592:standards*; D013903:Thoracic Surgery / Q000592:standards; D013988:Ticlopidine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000378:metabolism; D014481:United States; D014486:United States Food and Drug Administration / Q000592:standards
chemical_list: D000077144:Clopidogrel; D001189:Aryl Hydrocarbon Hydroxylases; C045793:CYP2C19 protein, human; D065731:Cytochrome P-450 CYP2C19; D013988:Ticlopidine